XGBoost combining MRI radiomics and clinical biomarkers reportedly reaches C-index 0.782 for early brain tumor recurrence, but the paper's methods describe a liver-cancer cohort and no evaluation of its claimed temporal module appears.
ForgetMe: Evaluating Selective Forgetting in Generative Models
1 Pith paper cite this work. Polarity classification is still indexing.
abstract
The widespread adoption of diffusion models in image generation has increased the demand for privacy-compliant unlearning. However, due to the high-dimensional nature and complex feature representations of diffusion models, achieving selective unlearning remains challenging, as existing methods struggle to remove sensitive information while preserving the consistency of non-sensitive regions. To address this, we propose an Automatic Dataset Creation Framework based on prompt-based layered editing and training-free local feature removal, constructing the ForgetMe dataset and introducing the Entangled evaluation metric. The Entangled metric quantifies unlearning effectiveness by assessing the similarity and consistency between the target and background regions and supports both paired (Entangled-D) and unpaired (Entangled-S) image data, enabling unsupervised evaluation. The ForgetMe dataset encompasses a diverse set of real and synthetic scenarios, including CUB-200-2011 (Birds), Stanford-Dogs, ImageNet, and a synthetic cat dataset. We apply LoRA fine-tuning on Stable Diffusion to achieve selective unlearning on this dataset and validate the effectiveness of both the ForgetMe dataset and the Entangled metric, establishing them as benchmarks for selective unlearning. Our work provides a scalable and adaptable solution for advancing privacy-preserving generative AI.
citation-role summary
citation-polarity summary
fields
cs.LG 1years
2025 1verdicts
REJECT 1roles
background 1polarities
unclear 1representative citing papers
citing papers explorer
-
Multi-Modal Machine Learning Framework for Predicting Early Recurrence of Brain Tumors Using MRI and Clinical Biomarkers
XGBoost combining MRI radiomics and clinical biomarkers reportedly reaches C-index 0.782 for early brain tumor recurrence, but the paper's methods describe a liver-cancer cohort and no evaluation of its claimed temporal module appears.